.jpg "Ehud Marom, BSc photo")
CEO and Chairman
Mapi Pharma Ltd.
Ehud Marom is one of the founders of Mapi Pharma Ltd and has served as Mapi's chief executive officer and as chairman of Mapi's board of directors since the company inception in January 2008. Mr. Marom has over 40 years of management and operational experience in the life sciences industry. Prior to Mapi's founding, Mr. Marom served in various senior positions at multinational pharmaceutical companies, including as vice president of two divisions at Teva Pharmaceutical Industries Ltd. from 1992 to 1995, where he launched Copaxone (Glatiramer Acetate GA) and was the head of the Copaxone global operation team and headed the global operations of Teva Pharmaceutical Industries Ltd.’s chemical division. From 2000 to 2002, Mr. Marom served as president of Peptor Ltd., where he led the pharmaceutical development of the innovative diabetes product, DiaPep. From 2002 to 2004, Mr. Marom served as chief executive officer of Gamida-Cell Ltd., a stem cell development company. From 2005 to 2007, Mr. Marom served as chief executive officer of Makhteshim, a global leader in branded off-patent crop protection solutions (which later became ADAMA Agricultural Solutions and has since been acquired by China National Agrochemical Corporation, a subsidiary of China National Chemical Corporation). Mr. Marom served as vice president of supply of ADAMA from 2005 to 2009. He helped guide the product of Pharma Two B, P2B001, for the treatment of early diagnosed Parkinson disease, through a successful phase III. Mr. Maron serves as well as chief executive officer and chairman of Stem Cell Medicine Ltd. Ehud has a B.Sc. in chemical engineering with honors, from the Technion, Israel.